Sage Journals: Discover world-class research

Open access

Review article

First published 2023

Precision oncology with selective RET inhibitor selpercatinib in RET -rearranged cancers

Mohamed A. Gouda, Vivek Subbiah

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2026-4

Safety evaluation of selective RET inhibitors in patients with lung cancer: a real-world pharmacovigilance study

Yaokai Wang, Wenmei Jiang, Yun Cheng [...]

Tumori Journal

Retricted access

Research article

First published 2025-01

Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma

Sarah Hamidi, Sireesha Yedururi, Mimi I. Hu [...]

Thyroid®

Open access

Research article

First published 2022

Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321)

Shun Lu, Ying Cheng, Dingzhi Huang [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2023-01

Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series

Kevin J. Contrera, Maria K. Gule-Monroe, Mimi I. Hu [...]

Thyroid®

Retricted access

Other

First published 2003-9

RETMEN2A and RETMEN2B Oncoproteins are Targets of PP1 Inhibitor

Italia Bongarzone, Cristiana Carniti, Carla Perego [...]

Tumori Journal

Retricted access

Case report

First published 2023-01

A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion

Ayanthi Wijewardene, Karine Bastard, Bin Wang [...]

Thyroid®

Open access

Review article

First published 2022

RET kinase inhibitors for RET -altered thyroid cancers

Danica M. Vodopivec, Mimi I. Hu

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2023-03-16

A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion

Ayanthi Wijewardene, Karine Bastard, Bin Wang [...]

VideoEndocrinology™

Open access

Research article

First published 2021

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian Johannes Hochmair, Hannah Fabikan [...]

Therapeutic Advances in Medical Oncology

Search results